| CAPMATINIB                                                                                                                                                                                                                                                         
  |  CAPMATINIB |  ATC L01EX17
  ANTINEOPLASTIC   TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC)   MET KINASE INHIBITOR  |  ORAL | Tmax 1.5 HOUR F 70 PERCENT VD 164 LITER PPB 96 PERCENT Cl 24 LITER / HOUR HT 6.5 HOUR SOLUBILITY LOW SOLUBILITY IN WATER  |  MET |   Hepatocyte growth factor receptor UNIPROT P08581 MET  more at DrugCentral  | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com VigiAccess SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank  |